By selectively borrowing habits from the West, the urban Indian has worsened his chances with cancer. Doctors say that while the city-bred Indian has willingly adopted a western diet, lapping up high-fat foods and shunning high-fibre content, he or she hasn't picked up the healthy western attitude of detecting and treating cancer early. The end-result, as the India's Million Death Study (MDS) reported on Thursday shows, is that urban Indians are...
More »SEARCH RESULT
Total Matching Records found : 334
Cheap generics no panacea for India's poorest
-Reuters Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital. "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...
More »Soft drink increases risk of heart attack: Study
-PTI Drinking just one can of soft drink daily may increase risk of heart attack, claims a new Harvard study but experts in India are sceptical about the findings even as they agree that excess consumption of such beverages is dangerous for health. The study, which surveyed over 40,000 men in the US for over a period of 22 years, found that taking just one sugar- sweetened drink a day increase the...
More »UN health agency unveils new data to help countries reduce deaths from tobacco use
-The United Nations Tobacco use is responsible for five million or 12 per cent of all deaths of adults above the age of 30 globally each year, according to a United Nations report unveiled today, that for the first time provides estimated mortality rates attributable to tobacco for 2004, the year before the international treaty on tobacco came into force. The Framework Convention on Tobacco Control (FCTC) that came into force in...
More »India's patent ruling on cancer may open door for cheaper HIV drugs
-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...
More »
